<DOC>
	<DOCNO>NCT01039987</DOCNO>
	<brief_summary>The Division Kidney Urology Hematology Disease ( DKUHD ) National Institute Diabetes Digestive Kidney Diseases ( NIDDK ) fund cooperative agreement ( UO1 ) consortium participate clinical center ( PCCs ) data coordinate image analysis center ( DCIAC ) develop implement study test whether image technique provide accurate reproducible marker progression renal disease patient polycystic kidney disease . The awarded participating clinical center Emory University , University Kansas , Mayo Foundation ( subcontract University Alabama ) . The awarded DCIAC Washington University St. Louis . Due relocation DCIAC P.I . Washington University University Pittsburgh , DCIAC CRISP II locate University Pittsburgh .</brief_summary>
	<brief_title>Consortium Radiologic Imaging Studies Polycystic Kidney Disease</brief_title>
	<detailed_description>The goal CRISP Study conduct prospective , longitudinal trial evaluate accuracy validity magnetic resonance image determine disease progression ADPKD define change renal renal cyst volume renal function time .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Polycystic Kidney Diseases</mesh_term>
	<mesh_term>Polycystic Kidney , Autosomal Dominant</mesh_term>
	<criteria>1 . CRISP I participant invite participate CRISP II . At entry CRISP I participants met number inclusion exclusion criterion . 1 . Current psychiatric addiction noncompliance disorder discretion principal investigator indicate subject successfully complete study ; 2 . Current medical problem discretion principal investigator would make unsafe participation study ; 3 . Inability provide write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Autosomal dominant polycystic kidney disease</keyword>
	<keyword>ADPKD</keyword>
	<keyword>kidney</keyword>
	<keyword>Biomarker</keyword>
	<keyword>MRI</keyword>
</DOC>